Ligand validation:1RDL

MMA: methyl alpha-D-mannopyranoside

MMA is a Ligand Of Interest in 1RDL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1RDL_MMA_2_1	63%	78%	0.114	0.908	0.4	0.5	-	-	0	0	100%	1
1RDL_MMA_1_1	48%	84%	0.126	0.883	0.35	0.42	-	-	0	0	92%	0.9231
1RDM_MMA_2_1	86%	79%	0.065	0.932	0.37	0.5	-	-	0	0	100%	1
2BV4_MMA_A_400	99%	50%	0.058	0.99	0.67	1.24	-	-	0	0	100%	0.9769
3ZDV_MMA_A_201	99%	58%	0.042	0.985	0.63	0.96	-	1	0	0	92%	0.9231
1MVQ_MMA_A_237	98%	52%	0.058	0.981	0.96	0.9	-	1	0	0	100%	1
2JDY_MMA_D_1115	98%	59%	0.059	0.978	0.7	0.87	-	-	0	0	100%	1
2VNV_MMA_A_201	98%	51%	0.06	0.979	1.01	0.9	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.